Oncology - Breast News & Articles

1 High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy European Journal of Cancer, June 19, 2013

2 Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group Breast Cancer Research and Treatment, June 19, 2013    Clinical Article

3 Moderate-to-vigorous intensity physical activity across the life course and risk of pre- and post-menopausal breast cancer Breast Cancer Research and Treatment, June 19, 2013

4 Estimating single nucleotide polymorphism associations using pedigree data: applications to breast cancer British Journal of Cancer, June 19, 2013    Clinical Article

5 Correlating transcriptional networks to breast cancer survival: A large-scale coexpression analysis. Carcinogenesis, June 19, 2013    Clinical Article

6 PPARγ maintains ERBB2-positive breast cancer stem cells Oncogene, June 19, 2013    Clinical Article

7 Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer Oncogene, June 19, 2013    Clinical Article

8 Case-only analyses of the associations between polymorphisms in the metastasis-modifying genes BRMS1 and SIPA1 and breast tumor characteristics, lymph node metastasis, and survival Breast Cancer Research and Treatment, June 19, 2013    Clinical Article

9 BreastPRS is a gene expression assay that stratifies intermediate-risk Oncotype DX patients into high- or low-risk for disease recurrence Breast Cancer Research and Treatment, June 19, 2013    Clinical Article

10 Human epidermal growth factor receptor 2-targeted therapies in breast cancer Expert Opinion on Biological Therapy, June 19, 2013    Review Article

11 Antiestrogens suppress effects of transforming growth factor-β in breast cancer cells via the signaling axis estrogen receptor-α and Y-box binding protein-1 Anticancer Research, June 19, 2013    Clinical Article

12 Lipid profiles for HER2-positive breast cancer Anticancer Research, June 19, 2013    Clinical Article

13 CD147 mediates chemoresistance in breast cancer via ABCG2 by affecting its cellular localization and dimerization Cancer Letters, June 19, 2013    Clinical Article

14 COX-2 promotes breast cancer cell radioresistance via p38/MAPK-mediated cellular anti-apoptosis and invasiveness Tumor Biology, June 19, 2013    Clinical Article

15 Disentangling breast cancer patients perceptions and experiences with regard to endocrine therapy: Nature and relevance for non-adherence The Breast, June 19, 2013    Clinical Article

16 Parkinsons disease genes do not segregate with breast cancer genes loci Cancer Epidemiology, Biomarkers & Prevention, June 19, 2013    Clinical Article

17 Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation International Journal of Clinical Oncology, June 19, 2013    Clinical Article

18 Intended follow-up of women with breast cancer at low risk of recurrence and at least 5 years from diagnosis Internal Medicine Journal, June 19, 2013    Evidence Based Medicine

19 Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status Cancer, June 19, 2013    Clinical Article

20 Molecular profiling of human mammary gland links breast cancer risk to a p27+ cell population with progenitor characteristics Cell Stem Cell, June 19, 2013    Review Article

1 Coffee and caffeine intake and breast cancer risk: An updated dose-response meta-analysis of 37 published studies Gynecologic Oncology, May 13, 2013    Evidence Based Medicine

2 Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: An International Tamoxifen Exemestane Adjuvant Multinational Trial analysis Journal of Clinical Oncology, April 30, 2013

3 Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial The Lancet Oncology, May 17, 2013

4 Neoadjuvant chemotherapy with or without zoledronic acid in early breast cancer: a randomized biomarker pilot study Clinical Cancer Research, May 6, 2013

5 Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study The Lancet Oncology, May 16, 2013

6 Is it safe and efficacious for women with lymphedema secondary to breast cancer to lift heavy weights during exercise: a randomised controlled trial Journal of Cancer Survivorship, May 21, 2013

7 Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab Clinical Cancer Research, May 8, 2013

8 Combination neratinib (HKI-272) and paclitaxel therapy in patients with HER2-positive metastatic breast cancer British Journal of Cancer, May 7, 2013

9 Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study Annals of Oncology, April 1, 2013

10 Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study The Lancet Oncology, May 2, 2013

11 Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: Results from the HERA Trial Journal of Clinical Oncology, April 25, 2013

12 Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA) Annals of Oncology, May 28, 2013

13 Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience Cancer Chemotherapy and Pharmacology, May 15, 2013

14 Use of {beta}-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: A Danish nationwide prospective cohort study Journal of Clinical Oncology, May 9, 2013

15 Which strategies reduce breast cancer mortality most? Cancer, May 1, 2013

16 Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer Clinical Cancer Research, May 24, 2013

17 Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer Journal of Clinical Oncology, May 1, 2013

18 Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer British Journal of Cancer, April 16, 2013

19 Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ Breast Cancer Research and Treatment, May 1, 2013

20 Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial European Journal of Cancer, April 2, 2013